Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. NEPH
NEPH logo

NEPH Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
3.692
Open
3.660
VWAP
3.63
Vol
9.46K
Mkt Cap
39.73M
Low
3.600
Amount
34.35K
EV/EBITDA(TTM)
44.33
Total Shares
10.86M
EV
35.73M
EV/OCF(TTM)
--
P/S(TTM)
2.11
Nephros, Inc. is a water technology company providing filtration solutions to the medical and commercial markets. The Company provides water filtration products and services, along with water-quality education. In the medical markets, it sells water filtration products. In the commercial market, it manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, heavy metals, chemical compounds, scale build-up in downstream equipment, and various other contaminants. Its products are marketed primarily to the food service, hospitality, convenience store, and healthcare markets. These commercial products are also marketed in medical markets as supplemental filtration to its medical filters. Its filters are primarily used in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, and in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate.
Show More

Events Timeline

(ET)
2026-02-13
08:20:00
Nephros Enters Puerto Rican Market to Address Water Quality Needs
select
2025-12-11 (ET)
2025-12-11
09:10:00
Nephros Launches Water Institute to Enhance Industry Education
select
2025-10-08 (ET)
2025-10-08
09:11:53
Nephros Introduces New Filter for PFAS Removal
select
2024-10-24 (ET)
2024-10-24
09:09:57
Nephros launches HydraGuard 20" UltraFilter
select

News

seekingalpha
9.5
05-08seekingalpha
Nephros Achieves Record Revenue in Q1 2026
  • Revenue Growth: Nephros achieved $5.2 million in revenue for Q1 2026, marking the first time it surpassed the $5 million threshold, reflecting a year-over-year increase of approximately 7%, indicating strong performance in key markets despite ongoing margin pressures and cost challenges.
  • Gross Margin Decline: The gross margin for the first quarter was 57%, down from 65% in the prior year, primarily due to tariffs and product mix changes that resulted in over $200,000 in additional costs, highlighting the challenges faced as the company expands into commercial applications.
  • Cash Flow Status: As of March 31, 2026, Nephros had approximately $4 million in cash and remained debt-free, although the cash balance declined due to the timing of inventory receipts and accounts receivable collections, demonstrating prudent financial management amid operational fluctuations.
  • Market Outlook: Management expressed optimism about future growth, emphasizing expansion in key markets such as New York and Puerto Rico, along with continued contributions from programmatic installations and replacements, although short-term margin variability may arise from tariffs and product mix fluctuations.
seekingalpha
9.5
05-07seekingalpha
Nephros Q1 Earnings Beat Expectations
  • Earnings Performance: Nephros reported Q1 GAAP EPS of $0.01, aligning with market expectations, while revenue reached $5.21 million, reflecting a 6.8% year-over-year increase and beating estimates by $0.22 million, indicating stability in revenue growth.
  • Market Reaction: Despite the earnings beat, Nephros shares fell 6.8% in after-hours trading, reflecting investor concerns about future growth prospects, which may impact short-term market confidence in the company.
  • Historical Performance Comparison: Compared to historical data, Nephros's revenue growth rate shows some improvement, suggesting a gradual strengthening in market competitiveness, yet ongoing scrutiny of its sustained profitability is necessary.
  • Future Outlook: Investors should closely monitor Nephros's upcoming earnings reports and market strategies to assess its long-term growth potential in the medical device industry and its ability to navigate market fluctuations.
Yahoo Finance
9.5
03-14Yahoo Finance
Nephros Reports Significant Growth in 2025 Financials
  • Significant Revenue Growth: Nephros reported total revenue of $18.8 million for 2025, a 33% increase from $14.2 million in 2024, indicating strong market performance and growth potential.
  • Sustained Profitability: The company achieved a net income of $1.2 million in 2025, a substantial rise from $0.1 million in 2024, marking its second consecutive year of profitability and boosting investor confidence.
  • Expanded Customer Base: By the end of 2025, active customer sites exceeded 1,680, up from over 1,500 in 2024, demonstrating success in market penetration and customer acquisition.
  • Increased R&D Investment: R&D expenses reached $1.3 million in 2025, up 57% from $0.9 million in 2024, reflecting the company's commitment to innovation and product development, although this has impacted short-term profitability.
NASDAQ.COM
2.0
03-13NASDAQ.COM
Nephros (NEPH) Q4 2025 Earnings Call Transcript
seekingalpha
9.5
03-12seekingalpha
Nephros Q4 Earnings Beat Expectations
  • Earnings Highlights: Nephros reported a Q4 GAAP EPS of $0.01, meeting market expectations, while revenue reached $4.7 million, reflecting a 20.5% year-over-year increase and beating estimates by $0.25 million, indicating robust performance in the market.
  • Growth Drivers: The significant revenue growth is primarily attributed to ongoing innovations in the medical device sector and increased market demand, further solidifying the company's competitive position within the industry.
  • Market Reaction: Following the earnings release, investors expressed optimism regarding Nephros's future growth prospects, anticipating continued benefits from the expansion of the healthcare sector and technological advancements.
  • Future Outlook: Nephros's sustained growth and improved profitability may attract more investor interest, potentially enhancing the company's performance in future capital markets.
Newsfilter
7.5
02-13Newsfilter
Nephros Enters Puerto Rican Market with Filtration Solutions
  • Market Opportunity: Nephros estimates a $10 million opportunity in Puerto Rico across healthcare, foodservice, and hospitality sectors, with healthcare and foodservice each representing $3 million, highlighting urgent needs for water safety.
  • Localized Service: The company plans to differentiate itself by offering rapid response from a dedicated inventory network, on-site installation, and Spanish-language customer support, thereby enhancing its competitive edge in the market.
  • Technological Advantage: Nephros' filtration solutions focus on microbial control and compliance with drinking water contaminants, aiming to fill the long-standing gap in high-quality filtration in Puerto Rico, thereby enhancing public health safety.
  • Strategic Expansion: This market entry is a natural extension of Nephros' core strategy, aiming to leverage advanced technology to meet critical water safety needs while expanding into sectors beyond traditional patient care, driving overall company growth.
Wall Street analysts forecast NEPH stock price to rise
1 Analyst Rating
Wall Street analysts forecast NEPH stock price to rise
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 0.000
sliders
Low
8.00
Averages
8.00
High
8.00
Current: 0.000
sliders
Low
8.00
Averages
8.00
High
8.00
Maxim
Maxim
NULL -> Buy
upgrade
$6
AI Analysis
2025-08-08
Reason
Maxim
Maxim
Price Target
$6
AI Analysis
2025-08-08
upgrade
NULL -> Buy
Reason
Maxim raised the firm's price target on Nephros to $6 from $4.50 and keeps a Buy rating on the shares. The company's Q2 results saw revenue, gross margins, and earnings all above consensus estimates, the analyst tells investors in a research note.

Valuation Metrics

The current forward P/E ratio for Nephros Inc (NEPH.O) is 0.00, compared to its 5-year average forward P/E of -24.01. For a more detailed relative valuation and DCF analysis to assess Nephros Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-24.01
Current PE
0.00
Overvalued PE
111.29
Undervalued PE
-159.32

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-4.47
Current EV/EBITDA
64.69
Overvalued EV/EBITDA
23.70
Undervalued EV/EBITDA
-32.63

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
2.30
Current PS
1.69
Overvalued PS
4.12
Undervalued PS
0.49

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

stocks that will explode in next 30 days
Intellectia · 640 candidates
Relative Vol: >= 1.50Moving Average Relationship: PriceAboveMA5, PriceAboveMA20Month Price Change Pct: >= $0.00One Month Rise Prob: >= 70One Month Predict Return: >= 0.0%
Ticker
Name
Market Cap$
top bottom
PRCH logo
PRCH
Porch Group Inc
1.23B
ROMA logo
ROMA
Roma Green Finance Ltd
396.70M
MCBS logo
MCBS
Metrocity Bankshares Inc
921.13M
UA logo
UA
Under Armour Inc
2.59B
INNV logo
INNV
InnovAge Holding Corp
1.08B
DOCN logo
DOCN
DigitalOcean Holdings Inc
15.94B
en español
Intellectia · 10 candidates
Price: <= $173.00Beta: LowRiskCurrent Ratio: >= 1.50Debt Equity: <= 0.500Return On Equity: >= 10.0%
Ticker
Name
Market Cap$
top bottom
MNST logo
MNST
Monster Beverage Corp
79.72B
GMED logo
GMED
Globus Medical Inc
12.60B
NYT logo
NYT
New York Times Co
11.51B
CALM logo
CALM
Cal-Maine Foods Inc
3.79B
COCO logo
COCO
Vita Coco Company Inc
3.05B
COLM logo
COLM
Columbia Sportswear Co
2.89B

Whales Holding NEPH

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Nephros Inc (NEPH) stock price today?

The current price of NEPH is 3.6 USD — it has decreased -1.64

What is Nephros Inc (NEPH)'s business?

Nephros, Inc. is a water technology company providing filtration solutions to the medical and commercial markets. The Company provides water filtration products and services, along with water-quality education. In the medical markets, it sells water filtration products. In the commercial market, it manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, heavy metals, chemical compounds, scale build-up in downstream equipment, and various other contaminants. Its products are marketed primarily to the food service, hospitality, convenience store, and healthcare markets. These commercial products are also marketed in medical markets as supplemental filtration to its medical filters. Its filters are primarily used in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, and in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate.

What is the price predicton of NEPH Stock?

Wall Street analysts forecast NEPH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for NEPH is8.00 USD with a low forecast of 8.00 USD and a high forecast of 8.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Nephros Inc (NEPH)'s revenue for the last quarter?

Nephros Inc revenue for the last quarter amounts to 5.21M USD, increased 6.87

What is Nephros Inc (NEPH)'s earnings per share (EPS) for the last quarter?

Nephros Inc. EPS for the last quarter amounts to 0.01 USD, decreased -80.00

How many employees does Nephros Inc (NEPH). have?

Nephros Inc (NEPH) has 36 emplpoyees as of June 01 2026.

What is Nephros Inc (NEPH) market cap?

Today NEPH has the market capitalization of 39.73M USD.